Education
About Us
Working with TipRanks
Follow Us
Agilon Health (AGL)
NYSE:AGL
AGL Analyst Ratings
Hold
3 Buy
11 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AGL Stock 12 Month Forecast
Average Price Target
$3.22
▼(-20.88% Downside)
| Highest Price Target$5.00 | Average Price Target$3.22 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Needham
Reiterated
03/21/25
Wells Fargo
Reiterated
03/14/25
Bernstein
Reiterated
03/10/25
Truist Financial
Reiterated
03/05/25
Bank of America Securities
Reiterated
02/27/25
Benchmark Co.
Reiterated
02/27/25
Barclays
Reiterated
02/27/25
Stifel Nicolaus
Reiterated
02/26/25
William Blair
Reiterated
02/26/25
Leerink Partners
Reiterated
02/26/25
TD Cowen
$2→$3.5
Hold
-14.00%
Downside
Reiterated
02/26/25
TD Cowen Sticks to Their Hold Rating for Agilon Health (AGL)
Evercore ISI
$3
Hold
-26.29%
Downside
Reiterated
02/26/25
Analysts Conflicted on These Healthcare Names: Agilon Health (NYSE: AGL), AN2 Therapeutics, Inc. (NASDAQ: ANTX) and Alcon (NYSE: ALC)
JMP Securities
―
Hold
―
Reiterated
02/26/25
Analysts Offer Insights on Healthcare Companies: AxoGen (NASDAQ: AXGN), Agilon Health (NYSE: AGL) and LAVA Therapeutics (NASDAQ: LVTX)
RBC Capital
$3→$3.5
Buy
-14.00%
Downside
Reiterated
02/25/25
Agilon Health (AGL) Receives a Buy from RBC Capital
BTIG
―
Hold
―
Reiterated
02/25/25
Agilon Health: Navigating Financial Challenges with Strategic Adjustments Amid Hold RatingWe like the steps being taken to improve financial discipline, and reduce risk in low or no margin areas.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Needham
Reiterated
03/21/25
Wells Fargo
Reiterated
03/14/25
Bernstein
Reiterated
03/10/25
Truist Financial
Reiterated
03/05/25
Bank of America Securities
Reiterated
02/27/25
Benchmark Co.
Reiterated
02/27/25
Barclays
Reiterated
02/27/25
Stifel Nicolaus
Reiterated
02/26/25
William Blair
Reiterated
02/26/25
Leerink Partners
Reiterated
02/26/25
TD Cowen
$2→$3.5
Hold
-14.00%
Downside
Reiterated
02/26/25
TD Cowen Sticks to Their Hold Rating for Agilon Health (AGL)
Evercore ISI
$3
Hold
-26.29%
Downside
Reiterated
02/26/25
Analysts Conflicted on These Healthcare Names: Agilon Health (NYSE: AGL), AN2 Therapeutics, Inc. (NASDAQ: ANTX) and Alcon (NYSE: ALC)
JMP Securities
―
Hold
―
Reiterated
02/26/25
Analysts Offer Insights on Healthcare Companies: AxoGen (NASDAQ: AXGN), Agilon Health (NYSE: AGL) and LAVA Therapeutics (NASDAQ: LVTX)
RBC Capital
$3→$3.5
Buy
-14.00%
Downside
Reiterated
02/25/25
Agilon Health (AGL) Receives a Buy from RBC Capital
BTIG
―
Hold
―
Reiterated
02/25/25
Agilon Health: Navigating Financial Challenges with Strategic Adjustments Amid Hold RatingWe like the steps being taken to improve financial discipline, and reduce risk in low or no margin areas.
AGL Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
3
3
4
1
1
Buy
0
0
1
4
5
Hold
10
14
17
18
16
Sell
5
5
3
2
2
Strong Sell
0
0
0
0
0
total
18
22
25
25
24
Each month's total comprises the sum of three months' worth of ratings.
AGL Financial Forecast
AGL Stock Forecast FAQ
What is AGL’s average 12-month price target, according to analysts?
Based on analyst ratings, Agilon Health’s 12-month average price target is $3.22.
What is AGL’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AGL, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AGL a Buy, Sell or Hold?
Agilon Health has a consensus rating of Hold which is based on 3 buy ratings, 11 hold ratings and 2 sell ratings.
What is Agilon Health’s price target?
The average price target for Agilon Health is $3.22. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $5.00 ,the lowest forecast is $2.00. The average price target represents -20.88% Decrease from the current price of $4.07.
The highest analyst price target is $5.00 ,the lowest forecast is $2.00. The average price target represents -20.88% Decrease from the current price of $4.07.
What do analysts say about Agilon Health?
Agilon Health’s analyst rating consensus is a Hold. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of AGL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.